Replay available

Bayer Ag S/Adr (BAYRY) Q1 2025 Earnings Call

Bayer Ag S/Adr (OTC: BAYRY) Q1 2025 earnings conference call, held 2025-05-13. Replay captured from the company's public earnings webcast.

Tue, May 13, 2025 at 8:00 AMendedReplay
Bayer Ag S/Adr (BAYRY) Q1 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Bill Anderson

President and Chief Executive Officer

Wolfgang Nickl

Chief Financial Officer

Rodrigo Costa

President, Crop Science Division

Stefan Oelrich

President, Pharmaceuticals Division

Richard Foster

Analyst, J.P. Morgan

Sachin Jain

Analyst, Bank of America

James Quiddingham

Analyst, Goldman Sachs

Joe Walton

Analyst, UBS

Christian Feitz

Analyst, Kepler Cheuvreux

Vincent Andrews

Analyst, Morgan Stanley

Laurent Favre

Analyst, BNP Paribas

Replay transcript excerpt

Good afternoon and good morning, everybody, and welcome to our conference call to discuss the first quarter results for 2025. To kick things off, Bill will share his insights on our overall business performance and the progress we've made on our strategic priorities thus far. Wolfgang will then provide further insights into the quarter one financials, the current geopolitical environment and our outlook for the remainder of the year. The presentations will be followed by our Q&A session, which will also include the presidents of our three divisions. As a reminder, we invite you also to join us for a crop science webinar later today. We start that at 4 p.m. Central European time or 10 a.m. Eastern time, and where we will delve further into the division strategy and outlook. Before we begin, please note the cautionary language in our safe harbor statement. And with that, over to you, Bill. Thanks, Joost. And yeah, hi, everyone. Thanks for joining our call today. We're looking forward to going through our Q1 business results with you. And we're also aware that the present geopolitical and economic uncertainty is top of mind. So Wolfgang and I will try to give you a sense of how we're approaching that as well. So let's start with our first quarter performance. First, a reminder that we speak about our sales growth in currency and portfolio adjusted terms. As a group, our sales are flat year over year, positioning us well within the minus 3% to plus 1% corridor that we guided for in 2025. Core EPS came in at 249 euros, and we're on track to reach our outlook of four euros, 50 to five euros at constant currencies. Free cash flow is at minus 1.5 billion euros. And as we've explained before, the negative figure is due to the seasonality of the crop business. It's also 1 bill...

More from Bayer Ag